Perceptive Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,215,346
| Closed | -$30.8M | – | 104 |
|
|
2024
Q2 | $30.8M | Sell |
1,215,346
-196,687
| -14% | -$4.98M | 0.74% | 41 |
|
|
2024
Q1 | $43.7M | Sell |
1,412,033
-336,900
| -19% | -$10.4M | 0.76% | 43 |
|
|
2023
Q4 | $70.6M | Hold |
1,748,933
| – | – | 1.58% | 19 |
|
|
2023
Q3 | $46.1M | Hold |
1,748,933
| – | – | 1.54% | 19 |
|
|
2023
Q2 | $30.1M | Sell |
1,748,933
-158,100
| -8% | -$2.72M | 0.87% | 37 |
|
|
2023
Q1 | $31.6M | Buy |
1,907,033
+210,000
| +12% | +$3.48M | 0.93% | 36 |
|
|
2022
Q4 | $12.9M | Hold |
1,697,033
| – | – | 0.36% | 55 |
|
|
2022
Q3 | $16.9M | Hold |
1,697,033
| – | – | 0.49% | 50 |
|
|
2022
Q2 | $15.4M | Sell |
1,697,033
-2,142,347
| -56% | -$19.5M | 0.48% | 46 |
|
|
2022
Q1 | $39M | Sell |
3,839,380
-3,289,375
| -46% | -$33.4M | 0.78% | 35 |
|
|
2021
Q4 | $119M | Sell |
7,128,755
-628,173
| -8% | -$10.5M | 1.83% | 14 |
|
|
2021
Q3 | $364M | Hold |
7,756,928
| – | – | 5.28% | 3 |
|
|
2021
Q2 | $473M | Hold |
7,756,928
| – | – | 6.14% | 2 |
|
|
2021
Q1 | $478M | Buy |
7,756,928
+1,050,660
| +16% | +$64.7M | 6.04% | 2 |
|
|
2020
Q4 | $477M | Hold |
6,706,268
| – | – | 5.12% | 3 |
|
|
2020
Q3 | $252M | Hold |
6,706,268
| – | – | 3.67% | 6 |
|
|
2020
Q2 | $219M | Hold |
6,706,268
| – | – | 3.54% | 8 |
|
|
2020
Q1 | $194M | Hold |
6,706,268
| – | – | 5.07% | 6 |
|
|
2019
Q4 | $142M | Hold |
6,706,268
| – | – | 2.83% | 10 |
|
|
2019
Q3 | $144M | Hold |
6,706,268
| – | – | 3.88% | 6 |
|
|
2019
Q2 | $181M | Buy |
+6,706,268
| New | +$181M | 4.15% | 7 |
|